Pooled week 96 results of the phase III DUET-1 and DUET-2 trials of etravirine: further analysis of adverse events and laboratory abnormalities of special interest.
Girard PM, Campbell TB, Grinsztejn B, Hartikainen J, Rachline A, Nijs S, Witek J. Pooled week 96 results of the phase III DUET-1 and DUET-2 trials of etravirine: further analysis of adverse events and laboratory abnormalities of special interest. HIV Med. 2012 Aug; 13(7):427-35.